Reports
Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
Global Hormonal Contraceptive Market: By Method: Pills, Intrauterine Devices (IUD), Injectable, Vaginal Ring, Implant, Patch; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis, EMR’s Key Indicators for Demand; Competitive Landscape; Industry Events and Developments
Global Hormonal Contraceptive Market Outlook
The global hormonal contraceptive market attained a value of USD 17.2 billion in 2020. The market is further expected to grow in the forecast period of 2022-2027 at a CAGR of 3.79% to reach USD 21.5 billion by 2026.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
North America to Provide Significant Growth Opportunities to the Hormonal Contraceptive Industry
Geographically, North America is a significant region contributing to the growth of the hormonal contraceptive industry globally. The market growth in the region can be attributed to the increased awareness among people regarding hormonal contraceptives and their benefits. Hormonal contraceptives help prevent unwanted pregnancy. These are reliable and also provide relief from period pain and lead to lighter periods. They can be taken as pills, or can be injected, or inserted under the skin. Hormonal birth control also has some long-term advantages like it reduces the risk of uterus cancer and also reduces the risk of ovary cysts. These factors are driving the demand for hormonal contraceptives in the region. In addition, the availability of advanced healthcare infrastructure and clinical facilities are also enhancing the regional market growth.
Hormonal Contraceptive: Market Segmentation
Hormonal contraceptive refers to a type of birth control method that targets the endocrine system to prevent pregnancy. Hormonal contraceptives help prevent pregnancy by blocking the release of eggs from the ovaries. They contain estrogen and progesterone, or progesterone only, and may be taken by mouth, injected, or inserted under the skin. They influence hormone levels in women and prevent mature eggs from being released. However, they can have side effects such as headaches, nausea, mood swings, and other issues.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Based on method, the market can be segmented into:
- Pills
- Intrauterine Devices (IUD)
- Injectable
- Vaginal Ring
- Implant
- Patch
The EMR report looks into the regional markets of hormonal contraceptive like North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Various Benefits of Hormonal Contraceptives and the Improving Healthcare Facilities to Bolster the Global Market for Hormonal Contraceptive
The high rates of efficacy and reliability of hormonal contraceptives and the innovations in the market are the key drivers for the hormonal contraceptive industry growth globally. Hormonal contraceptives can also relieve the symptoms of premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). Furthermore, hormonal birth control methods allow women to skip their periods by taking pills, contraceptive coils, or others, and, thus, help avoid menstrual migraines. They also reduce the risk of anaemia, as some women experience high bleeding during their periods, which may lead to fatigue and weakness. These factors are driving the growth of the industry. In addition, the growing research and development activities in the pharmaceutical sector and the improving healthcare infrastructure particularly in emerging economies are expected to further propel the market forward.
Key Industry Players in the Global Hormonal Contraceptive Market
The report presents a detailed analysis of the following key players in the global hormonal contraceptive market, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions.
- Allergan Inc.
- Pfizer Inc.
- Bayer AG
- Afaxys, Inc.
- Merck and Co., Inc.
- Others
The comprehensive report looks into the macro and micro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
|---|---|
| Base Year | 2020 |
| Historical Period | 2017-2021 |
| Forecast Period | 2022-2027 |
| Scope of the Report | Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Method, Region |
| Breakup by Method | Pills, Intrauterine Devices (IUD), Injectable, Vaginal Ring, Implant, Patch |
| Breakup by Region | North America, Europe, Asia Pacific, Latin America, Middle East and Africa |
| Market Dynamics | SWOT, Porter's Five Forces, Key Indicators for Price and Demand |
| Competitive Landscape | Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications |
| Companies Covered | Allergan Inc., Pfizer Inc., Bayer AG, Afaxys, Inc., Merck and Co., Inc., Others |
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*We at Expert Market Research always thrive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Hormonal Contraceptive Market Analysis
8.1 Key Industry Highlights
8.2 Global Hormonal Contraceptive Historical Market (2017-2021)
8.3 Global Hormonal Contraceptive Market Forecast (2022-2027)
8.4 Global Hormonal Contraceptive Market by Method
8.4.1 Pills
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2017-2021)
8.4.1.3 Forecast Trend (2022-2027)
8.4.2 Intrauterine Devices (IUD)
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2017-2021)
8.4.2.3 Forecast Trend (2022-2027)
8.4.3 Injectable
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2017-2021)
8.4.3.3 Forecast Trend (2022-2027)
8.4.4 Vaginal Ring
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2017-2021)
8.4.4.3 Forecast Trend (2022-2027)
8.4.5 Implant
8.4.5.1 Market Share
8.4.5.2 Historical Trend (2017-2021)
8.4.5.3 Forecast Trend (2022-2027)
8.4.6 Patch
8.4.6.1 Market Share
8.4.6.2 Historical Trend (2017-2021)
8.4.6.3 Forecast Trend (2022-2027)
8.5 Global Hormonal Contraceptive Market by Region
8.5.1 Market Share
8.5.1.1 North America
8.5.1.2 Europe
8.5.1.3 Asia Pacific
8.5.1.4 Latin America
8.5.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2017-2021)
9.1.2 Forecast Trend (2022-2027)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2017-2021)
9.2.2 Forecast Trend (2022-2027)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2017-2021)
9.3.2 Forecast Trend (2022-2027)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2017-2021)
9.4.2 Forecast Trend (2022-2027)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2017-2021)
9.5.2 Forecast Trend (2022-2027)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 Key Indicators for Demand
10.4 Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Allergan Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Pfizer Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Bayer AG
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Afaxys, Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Merck and Co., Inc.
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Key Figures and Tables
1. Global Hormonal Contraceptive Market: Key Industry Highlights, 2016 and 2026
2. Global Hormonal Contraceptive Historical Market: Breakup by Method (USD Billion), 2017-2021
3. Global Hormonal Contraceptive Market Forecast: Breakup by Method (USD Billion), 2022-2027
4. Global Hormonal Contraceptive Historical Market: Breakup by Region (USD Billion), 2017-2021
5. Global Hormonal Contraceptive Market Forecast: Breakup by Region (USD Billion), 2022-2027
6. North America Hormonal Contraceptive Historical Market: Breakup by Country (USD Billion), 2017-2021
7. North America Hormonal Contraceptive Market Forecast: Breakup by Country (USD Billion), 2022-2027
8. Europe Hormonal Contraceptive Historical Market: Breakup by Country (USD Billion), 2017-2021
9. Europe Hormonal Contraceptive Market Forecast: Breakup by Country (USD Billion), 2022-2027
10. Asia Pacific Hormonal Contraceptive Historical Market: Breakup by Country (USD Billion), 2017-2021
11. Asia Pacific Hormonal Contraceptive Market Forecast: Breakup by Country (USD Billion), 2022-2027
12. Latin America Hormonal Contraceptive Historical Market: Breakup by Country (USD Billion), 2017-2021
13. Latin America Hormonal Contraceptive Market Forecast: Breakup by Country (USD Billion), 2022-2027
14. Middle East and Africa Hormonal Contraceptive Historical Market: Breakup by Country (USD Billion), 2017-2021
15. Middle East and Africa Hormonal Contraceptive Market Forecast: Breakup by Country (USD Billion), 2022-2027
16. Global Hormonal Contraceptive Market Structure
Key Questions Answered in the Report
In 2020, the global hormonal contraceptive market attained a value of nearly USD 17.2 billion.
The market is projected to grow at a CAGR of 3.79% between 2021 and 2026.
The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 21.5 billion by 2026.
The major drivers of the industry, such as the rising consumer awareness regarding contraceptives, increased investment by the key players to develop improved solutions and formulations, favourable government policies to control population explosion, and growing demand for oral pills, are expected to aid the market growth.
The key market trends guiding the growth of the market include the growing shift towards family planning, increasing R&D activities, and rapid technological advancements.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Pills, intrauterine devices (IUD), injectable, vaginal ring, implant, and patch, among others, are the major methods of hormonal contraceptive in the industry.
The major players in the industry are Allergan Inc., Pfizer Inc., Bayer AG, Afaxys, Inc., and Merck and Co., Inc., among others.
Analyst Review
The global hormonal contraceptive market attained a value of USD 17.2 billion in 2020, driven by the increased government initiatives to promote awareness regarding contraceptives and the growing focus on controlling birth rates. Aided by the growing research and development activities and new product launches, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 3.79% to reach a value of USD 21.5 billion by 2026.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on method, the market is segmented into pills, intrauterine devices (IUD), injectable, vaginal ring, implant, and patch, among others. The major regional markets for hormonal contraceptive are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Allergan Inc., Pfizer Inc., Bayer AG, Afaxys, Inc., and Merck and Co., Inc., among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$2699-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$3699-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$4699-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar Reports
The India sexual wellness market is driven by the increasing sexual liberation among the young population. Aided by the proliferation of various start-ups and direct-to-consumer (D2C) brands of sexual...
The atopic dermatitis treatment market attained a value of USD 9.67 billion in 2021, driven by the rising inclination towards renewable energy sources and carbon emission control. Aided by the growing...
The Europe compression bandages market attained a value of nearly USD 398.11 million in 2021, driven by the rising prevalence of acute injuries, such as sprains and strains, and diseases like lymphede...
The global bone and joint health ingredients market attained a value of USD 3.26 billion in 2021, driven by rising healthcare awareness, especially among the ageing population. Aided by the growing ph...
The global human papillomavirus (HPV) vaccine market attained a value of nearly USD 4.2 billion in 2021, driven by the increasing awareness about human papillomavirus. Aided by the growing demand for ...
NEWSLETTER